This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04657991
Recruitment Status : Active, not recruiting
First Posted : December 8, 2020
Last Update Posted : April 15, 2024
Merck Sharp & Dohme LLC
Information provided by (Responsible Party):